|
|
||||||||
School of Biomedical Sciences, University Medical School, Queen's Medical Center, Nottingham NG7 2UH; and Cardiovascular and Musculoskeletal Research Department, Zeneca Pharmaceuticals, Macclesfield SK10 4TG, United Kingdom
Pyruvate
dehydrogenase complex (PDC) activation status has been described as
being central in the regulation of tissue substrate oxidation as
outlined by the glucose fatty-acid cycle. In the present study we
examined the effects of reduced lipolysis, with use of nicotinate, and
increased PDC activation, with use of dichloroacetate (DCA), on
substrate utilization during 20 min of submaximal steady-state contraction (~80% of maximal O2
uptake) in canine gracilis skeletal muscle. At rest, PDC activation was
unchanged by nicotinate but was ~2.5-fold higher in the DCA group
than in the control group (P < 0.05). During contraction, PDC activation status increased to 3.5 mmol
acetyl-CoA · min
1 · kg
1
at 37°C in the control group, remained at 4.5 mmol
acetyl-CoA · min
1 · kg
1
at 37°C in the DCA group, but only increased to 2.2 mmol
acetyl-CoA · min
1 · kg
1
at 37°C in the nicotinate group (P < 0.05). However, the estimated amount of carbohydrate oxidized
during the 20-min contraction was similar across groups and did not
follow the degree of PDC activation (81.2 ± 22.9, 95.9 ± 11.7, and 89.3 ± 18.9 mmol glucosyl units/kg dry muscle for
control, nicotinate, and DCA, respectively). Thus it would appear that,
during steady-state contraction, PDC activation status does not
determine the rate of carbohydrate oxidation in skeletal muscle.
pyruvate dehydrogenase complex; glucose-fatty acid cycle; lipid; glycogen; acetylcarnitine
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |